You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 4,584,305


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,584,305
Title: Aiding the regression of neoplastic disease with 2,3,5,6-tetrahydro-6-phenylimidazo[2,1-b]thiazole
Abstract:Process of aiding regression and palliation of neoplastic disease in animal and human hosts comprising systemic administration to phenylimidazo[2,1-b]thiazole or a nontoxic acid addition salt thereof. Preferably the active ingredient is administered in a sufficient amount to provide dosages over the range from about 1 mg to about 5 mg/kg of body weight of the host.
Inventor(s): Brugmans; Josephus (Schilde-Antwerp, BE), Pollack; William (Belle Mead, NJ), Janssen; Paul A. J. (Vosselaar, BE), Tripodi; Daniel (Westford, MA)
Assignee: Janssen Pharmaceutica N.V. (Beerse, BE)
Application Number:06/230,578
Patent Claim Types:
see list of patent claims
Composition; Compound; Process; Use;
Patent landscape, scope, and claims:

United States Patent 4,584,305: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 4,584,305, though not directly provided in the sources, can be analyzed through the context of patent analytics, claim coverage, and the broader patent landscape. Here, we will delve into the general principles and processes that apply to such patents, using relevant examples and guidelines.

Understanding the Patent

To analyze the scope and claims of a patent like 4,584,305, it is crucial to understand the patent's subject matter, inventors, assignees, and the specific claims made.

Subject Matter and Inventors

Patents typically involve innovative methods, products, or processes. For example, the patent mentioned in the sources (US 6,858,598 B1) involves a combination therapy for the treatment of neoplasia, indicating the complexity and specificity of medical patents[1].

Assignees and Ownership

The assignee of a patent, such as G. D. Searle & Co. in the case of US 6,858,598 B1, holds the rights to the patent and is responsible for its enforcement and maintenance[1].

Claims Analysis

Claim Structure

Patent claims are the most critical part of a patent application, defining the scope of protection. Claims can be independent or dependent, with dependent claims building upon independent ones[3].

Claim Coverage Matrix

A Claim Coverage Matrix helps in categorizing patents by claims and scope concepts, making it easier to understand which patents and claims are actively protecting the intellectual property. This matrix can highlight gaps or opportunities in the patent landscape[3].

Scope Concepts

Scope concepts are overarching categories that link claims on similar patents, facilitating the filtering, searching, and analysis of large numbers of patent claims. This method is particularly useful for companies with extensive patent portfolios[3].

Patent Landscape Analysis

Tracking Patents by Claims and Scope Concepts

Analyzing patents by their claims and scope concepts provides a comprehensive view of the patent landscape. This involves categorizing patents not just by individual claims but also by broader scope concepts that can link multiple patents[3].

Claim Charts

Interactive claim charts generated by tools like ClaimScape® software can help technical experts, engineers, and management review patent coverage. These charts are updated as new patents are filed or as development avenues are explored, helping to identify gaps in coverage and future design opportunities[3].

Patent Term and Exclusivity

Patent Term Extension

Under 35 U.S.C. 156, the term of a patent can be extended if the patent claims a product or method subject to regulatory reviews by the FDA or the Department of Agriculture. This extension can be up to five years and is calculated based on the time spent in regulatory review[2].

Example of Patent Term Extension

For instance, U.S. Patent No. 4,201,772 had its original expiration date changed due to the Uruguay Round Agreements Act (URAA) and was further extended due to regulatory review periods[2].

Regulatory and Exclusivity Information

FDA Orange Book

The FDA Orange Book provides information on drug patents and exclusivity, including the expiration dates of patents and exclusivity periods. This is crucial for understanding the market protection and competitive landscape of pharmaceutical products[4].

Therapeutic Equivalence Evaluations

The Orange Book also includes therapeutic equivalence evaluations, which are important for determining the substitutability of generic drugs with their branded counterparts[4].

Maintaining and Updating Patent Coverage

Continuous Monitoring

The patent landscape is dynamic, with new patents being filed and existing ones expiring or being extended. Continuous monitoring using tools like Claim Coverage Matrices and interactive claim charts is essential for maintaining robust patent protection[3].

Updating Claim Charts

As new patents are filed or as development strategies evolve, claim charts need to be updated to reflect the current state of patent coverage. This helps in identifying new design opportunities and gaps in protection[3].

Key Takeaways

  • Claims Analysis: Understanding the structure and scope of patent claims is crucial for determining the protection offered by a patent.
  • Patent Landscape: Analyzing the patent landscape through claim coverage matrices and scope concepts helps in identifying gaps and opportunities.
  • Patent Term and Exclusivity: Regulatory reviews can extend the term of a patent, and understanding these extensions is vital for market strategy.
  • Continuous Monitoring: Regularly updating patent coverage is essential to maintain robust intellectual property protection.

Frequently Asked Questions (FAQs)

What is the importance of claim analysis in patent protection?

Claim analysis is critical because it defines the scope of protection for a patent. It helps in understanding what is protected and what is not, which is essential for enforcing patent rights and avoiding infringement.

How does the FDA Orange Book impact patent strategy?

The FDA Orange Book provides crucial information on drug patents and exclusivity, helping companies understand the market protection and competitive landscape of pharmaceutical products. This information is vital for planning patent strategies and ensuring compliance with regulatory requirements.

What is the role of scope concepts in patent analytics?

Scope concepts are overarching categories that link claims on similar patents, facilitating the analysis of large numbers of patent claims. They help in categorizing patents by broader concepts, making it easier to identify gaps and opportunities in the patent landscape.

Can patent terms be extended, and if so, how?

Yes, patent terms can be extended under 35 U.S.C. 156 if the patent claims a product or method subject to regulatory reviews by the FDA or the Department of Agriculture. The extension can be up to five years and is calculated based on the time spent in regulatory review.

Why is continuous monitoring of the patent landscape important?

Continuous monitoring is essential because the patent landscape is dynamic. New patents are filed, existing ones expire or are extended, and development strategies evolve. Regular updates help in maintaining robust patent protection and identifying new design opportunities and gaps in coverage.

Cited Sources:

  1. McKearn et al. US 6,858,598 B1, United States Patent and Trademark Office.
  2. United States Patent and Trademark Office, Extension Under 35 U.S.C. 156(e)(1), OG Date: 29 July 2003.
  3. Schwegman, Patent Analytics, SLWIP.
  4. FDA, The Cumulative Supplement, DrugPatentWatch.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 4,584,305

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.